Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy
- Conditions
- Laparoscopic Cholecystectomy
- Interventions
- Registration Number
- NCT04138472
- Lead Sponsor
- Sana Urooj
- Brief Summary
Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy
- Detailed Description
Direct laryngoscopy and intubation are painful stimulus that activates sympathoadrenal discharge which results in intense cardiovascular reflex i.e. tachycardia and hypertension. In this study we will compare effects of intravenous dexmedetomidine, fentanyl and lidocaine for attenuation of these reflexes in patient undergoing laproscopic cholecystectomy. how these agents will effect hemodynamic response during pneumoperitoneum. Tertiary objective will be to observe sedation, perioperative complications and recovery in these patients.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- ASA-I and ll patients
- Male and female patient of age 20-70 years.
- Undergoing Elective surgery
- Intubation by skilled anesthetist of at least 2 years' experience
- Intubation not more than 45 seconds
- Patients with uncontrolled DM, HTN, IHD, endocrine or autonomic dysfunction
- Pregnant and lactating females
- Short thick neck with anticipated difficult intubation
- Any sort of obstructive restrictive or reactive airway disease
- Patient allergic to any of the study medications.
- Obese patients, Narcotic addicts
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fentanyl fentanyl Group B receives intravenous fentanyl at 2mcg/kg in 100ml saline over 10 minutes in induction room. Lidocaine lidocaine Group C patients receives intravenous lidocaine 1.5mg/kg in 100ml saline over 10 minutes in induction room. Dexmedetomidine dexmedetomidine Group A patients receive intravenous dexmedetomidine 0.06mg/kg in 100ml normal saline 0.9% over 10minutes.
- Primary Outcome Measures
Name Time Method Heart rate at induction Hemodynamic responses (average heart rate beats a minute)
systolic blood pressure at induction hermodynamic response (Top number will be assessed of blood pressure)
mean atrial pressure at induction Hemodynamic responses (average blood pressure in an individual during a single cardiac cycle)
Oxygen saturation (SpO2) at induction Hemodynamic responses) (arterial oxy-hemoglobin saturation is measured non-invasively by a finger pulse oximeter or handheld pulse oximeter,
Diastolic blood pressure at induction hermodynamic response (bottom number will be assessed of blood pressure)
- Secondary Outcome Measures
Name Time Method Sedation assessment at 10 minutes post operative Ramsey score use for sedation, it consist of 1-6 where 6 indicates worst(no response) and 6 indicates good response
Recovery assessment at 10 minutes post operatively Aldret score use for recovery assessment, it consist of 0-10 point where 0 indicates worst(no response) and 10 indicates good response
Complications 1 week Post-operative(Operation -discharge) Cough, Laryngospasm, Bradycardia, Regugitation, PONV, Hypertention, Hypotension
Trial Locations
- Locations (1)
DUHS, Civil hospital Karachi (CHK)
🇵🇰Karachi, Sindh, Pakistan